The Centre of Excellence for Prevention of Organ Failure:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:The Centre of Excellence for Prevention of Organ Failure - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10290
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Centre of Excellence for Prevention of Organ Failure (PROOF Centre) is a healthcare center that provides blood-based biomarker tests. The center conducts biomarker programs to develop simple blood tests for transplant patients and patients with chronic organ disease and biomarkers in transplantation, chronic kidney disease, and others. It offers services such as chronic obstructive pulmonary disease, chronic heart failure, acute heart failure, recovered organ failure, and others. PROOF Centre provides blood-based biomarker tests for the prevention, diagnosis and treatment of heart, lung and kidney failure, among others. The center caters its clients across Canada. PROOF Centre is headquartered in Vancouver, British Columbia, Canada.

The Centre of Excellence for Prevention of Organ Failure – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment Deals By Type, 2012 to YTD 2018 6
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deal Details 10
Partnerships 10
HTG Molecular Diagnostics Enters Into Licensing Agreement With Centre of Excellence for Prevention of Organ Failure For COPD Prognostic Test 10
PROOF Centre Partners with AstraZeneca 11
Proof Centre Enters Into Co-Development Agreement With HTG Molecular Diagnostics 12
Proof Centre Enters Into Co-Development Agreement With AllerGen For Allergy Biomarkers 13
Proof Centre Enters Into Co-Development Agreement With IO Informatics 14
OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 15
Centre of Excellence for Prevention of Organ Failure Enters Into Co-Development Agreement With Adiga Life Sciences For Proteomic And Genomic Biomarkers 16
The Centre of Excellence for Prevention of Organ Failure – Key Competitors 17
The Centre of Excellence for Prevention of Organ Failure – Key Employees 18
The Centre of Excellence for Prevention of Organ Failure – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Key Facts 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment Deals By Type, 2012 to YTD 2018 6
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
The Centre of Excellence for Prevention of Organ Failure, Deals By Market, 2012 to YTD 2018 8
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
HTG Molecular Diagnostics Enters Into Licensing Agreement With Centre of Excellence for Prevention of Organ Failure For COPD Prognostic Test 10
PROOF Centre Partners with AstraZeneca 11
Proof Centre Enters Into Co-Development Agreement With HTG Molecular Diagnostics 12
Proof Centre Enters Into Co-Development Agreement With AllerGen For Allergy Biomarkers 13
Proof Centre Enters Into Co-Development Agreement With IO Informatics 14
OriGene Technologies Enters Into Co-Development Agreement With Centre of Excellence for Prevention of Organ Failure 15
Centre of Excellence for Prevention of Organ Failure Enters Into Co-Development Agreement With Adiga Life Sciences For Proteomic And Genomic Biomarkers 16
The Centre of Excellence for Prevention of Organ Failure, Key Competitors 17
The Centre of Excellence for Prevention of Organ Failure, Key Employees 18

List of Figures
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
The Centre of Excellence for Prevention of Organ Failure, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[The Centre of Excellence for Prevention of Organ Failure:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Blue Dolphin Energy Company (BDCO):石油・ガス:M&Aディール及び事業提携情報
    Summary Blue Dolphin Energy Company (Blue Dolphin) is an oil and gas company that refines and markets petroleum products. The company own and operate pipeline assets and have leasehold interests in oil and gas properties. It also acquires, develops and explores oil and gas properties. Blue Dolphin o …
  • Lanco Infratech Ltd (LITL):企業の財務・戦略的SWOT分析
    Lanco Infratech Ltd (LITL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Electromagnetic Geoservices ASA (EMGS):企業の財務・戦略的SWOT分析
    Summary Electromagnetic Geoservices ASA (EMGS) is an oil and gas service provider that explores workflow working with seismic, petrophysical and geologic data. The company gathers controlled source electromagnetic data and conduct modeling, integration, interpretation. Its technology finds applicati …
  • Alcoa Corp:企業のM&A・事業提携・投資動向
    Alcoa Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alcoa Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • BioElectronics Corp (BIEL):企業の財務・戦略的SWOT分析
    BioElectronics Corp (BIEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Amdocs Ltd (DOX):企業の財務・戦略的SWOT分析
    Amdocs Ltd (DOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Velan Inc (VLN):企業の財務・戦略的SWOT分析
    Velan Inc (VLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • iCAD Inc (ICAD):企業の財務・戦略的SWOT分析
    iCAD Inc (ICAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Fera Pharmaceuticals LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Fera Pharmaceuticals LLC (Fera) is a pharmaceutical company that develops, markets and commercializes ointments and medicines. The company offers neptazane, bacitracin ophthalmic ointment USP, neo-polycin HC, and others. It offers various treatment options for patient and healthcare communit …
  • Gannett Co., Inc.
    Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Gannett Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Electromed Inc (ELMD):企業の財務・戦略的SWOT分析
    Summary Electromed Inc (Electromed) is a medical device company that designs, manufactures and markets respiratory care products using airway clearance technologies. The company offers smartvest airway clearance system used through in-home and in-patient therapies for respiratory treatments. It offe …
  • Roper Technologies Inc (ROP):企業の財務・戦略的SWOT分析
    Roper Technologies Inc (ROP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Gore Mutual Insurance Company:企業の戦略・SWOT・財務情報
    Gore Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Gore Mutual Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • CBR Systems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CBR Systems Inc (CBR), a subsidiary of AMAG Pharmaceuticals Inc, is a stem cell company that offers new born stem cells. The company provides collection, processing, and long-term cryopreservation services for newborn umbilical cord blood stem cells and cord tissue units. It offers cord bloo …
  • Lutron Electronics Co Inc:企業の戦略的SWOT分析
    Lutron Electronics Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Levi Strauss & Co:企業の戦略的SWOT分析
    Levi Strauss & Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Barry Callebaut AG:企業の戦略・SWOT・財務情報
    Barry Callebaut AG - Strategy, SWOT and Corporate Finance Report Summary Barry Callebaut AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • BelAZ:企業の戦略・SWOT・財務分析
    BelAZ - Strategy, SWOT and Corporate Finance Report Summary BelAZ - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, provid …
  • OAO Tatneft:企業の戦略・SWOT・財務分析
    OAO Tatneft - Strategy, SWOT and Corporate Finance Report Summary OAO Tatneft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Aduro BioTech Inc (ADRO):企業の財務・戦略的SWOT分析
    Aduro BioTech Inc (ADRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆